Research report: PDF OnlyCholecystokinin octapeptide (CCK-8): Antagonism to electroacupuncture analgesia and a possible role in electroacupuncture toleranceHan, J. S.1; Ding, X. Z.; Fan, S. G.Author Information Department of Physiology, Beijing Medical University, Beijing 100083 People's Rep. of China 1To whom correspondence should be addressed. Submitted September 6, 1985; revised January 6, 1986; accepted January 20, 1986. Pain: October 1986 - Volume 27 - Issue 1 - p 101-115 doi: 10.1016/0304-3959(86)90227-7 Buy Metrics Abstract The analgesic effect produced by electroacupuncture (EA) stimulation in the rat was dose-dependently antagonized by cholecystokinin octapeptide (CCK-8) administered intracerebroventricularly (i.c.v.) or intrathecally (i.th) at a dose range of 0.25–4 ng. This effect had an immediate onset and lasted for at least 4 h. CCK-8 per se, however, did not affect baseline tail flick latency. Rats subjected to prolonged EA stimulation developed EA tolerance as well as cross-tolerance to morphine. These tolerances could be postponed or reversed by i.c.v. or i.th injection of antiserum against CCK-8. While CCK-8 antagonized opioid analgesia, it did not affect analgesia induced by 5-hydroxytryptamine (5-HT) or norepinephrine (NE). Moreover, CCK-8 antiserum did not alter the basic level of nociception, nor did it potentiate EA analgesia in naive rats. It is concluded that prolonged EA stimulation results in a profound release of opioids which may trigger the release of CCK-8 in the central nervous system to counteract the opioid component of EA analgesia. This mechanism may account, at least in part, for the development of EA tolerance. © Lippincott-Raven Publishers.